U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 11 - 20 of 23 results

mixture
Status:
Possibly Marketed Outside US
First approved in 2013

Class:
MIXTURE

Status:
Possibly Marketed Outside US
First approved in 2020

Class:
PROTEIN

Status:
US Approved Rx (2017)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. Irinotecan is sold under the brand name Camptosar among others. CAMPTOSAR is a topoisomerase inhibitor indicated for: • First-line therapy in comb...

Showing 11 - 20 of 23 results